Recursion Pharmaceuticals (RXRX) Notes Payables (2020 - 2024)
Recursion Pharmaceuticals (RXRX) recorded Notes Payables of $55,000 in Q1 2024, down 91.7% from $661,000 a year earlier but up 34.1% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Notes Payables (2020 - 2024) Analysis & Trends
At the end of FY2023, Recursion Pharmaceuticals reported Notes Payables of $41,000, down 57.7% from FY2022.
- Annual Notes Payables has a three-year compound annual growth rate of -66.3% (FY2020 to FY2023).
- Across earlier years, Notes Payables came in at $97,000 in FY2022 (+7.8%), $90,000 in FY2021 (-91.6%) and $1.07 million in FY2020.
- Quarterly Notes Payables has ranged from $41,000 in Q4 2023 to $3.14 million in Q2 2021 over the past five years.
- On a year-over-year basis, Notes Payables rose in five of the last eight quarters, with growth averaging 205.8%.
- Peak year-over-year performance for Notes Payables in the last five years was growth of 631.6% in Q3 2023, against a decline of 97.0% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $41,000 (Q4 2023), $695,000 (Q3 2023) and $676,000 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 695,000.00 |
| Jun 30, 2023 | 676,000.00 |
| Mar 31, 2023 | 661,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 93,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Sep 30, 2021 | 88,000.00 |
| Jun 30, 2021 | 3.14 Mn |
| Mar 31, 2021 | 2.15 Mn |
| Dec 31, 2020 | 1.07 Mn |
API Access
Recursion Pharmaceuticals Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();